Dr. Cody Visits Kernel Neuroscience Headquarters and tries on the Kernel Flow.
►►► INSTAGRAM (Behind The Scenes with Cody Rall MD):
https://www.instagram.com/codyrall_techforpsych/
►►► Dr. Cody’s presentation to Harvard/Digital Psychiatry: https://www.sodpsych.org/events.
►►► Kernel Lab and Aimlab footage posted with permission from Kernel: https://www.kernel.com/ and https://www.youtube.com/channel/UCXifD9arenz_20VlzLDHbwA
It’s no secret that our lungs play a vital role in our daily lives—ensuring we can breathe, fend off infections, and adapt to various challenges. Despite their importance, the organs still puzzle many medical experts, especially when they’re affected by diseases. While traditional tools like MRI and CT scans are helpful when a patient is experiencing a lung-related illness, they can still fall short in providing the detailed, real-time information needed to understand the intricacies of lung health.
Enter the groundbreaking innovation known as the crystal ribcage. Developed by researchers in Boston University’s College of Engineering, Pulmonary Center, Center for Multiscale and Translational Mechanobiology, and Neurophtonics Center, the technology is poised to revolutionize not only our understanding of lung function but also holds immense potential for other organs and treatments.
In new research, published this month in Nature Methods, the crystal ribcage acts as a clear, protective shield for a mouse’s lungs, allowing scientists to get a close view of how these organs work in real-time, and at a cellular level. What makes this technology special is that it doesn’t disrupt the lung’s natural processes—breathing and blood circulation continue as usual while the researchers observe.
Novo Nordisk A/S agreed to partner with the US technology company Valo Health Inc. to use artificial intelligence to find new drugs in a deal that could be worth as much as $2.7 billion.
The recent introduction of the breathtaking AI tool ChatGPT has sparked a national dialogue about the future of artificial intelligence in health care, education, research, and beyond. In this session, four UCSF experts discuss AI’s current and potential uses, in areas ranging from research to education to clinical care. After a brief presentation by each speaker, DOM Chair Bob Wachter moderates a far-ranging panel discussion on the health care applications of ChatGPT.
Speakers:
Atul Butte, MD, PhD, professor of Pediatrics, Bioengineering and Therapeutic Sciences, and Epidemiology and Biostatistics; director, UCSF Bakar Computational Health Sciences Institute; chief data scientist, University of California Health System.
Daniel Lowenstein, MD, professor of Neurology; former executive vice chancellor and provost, UCSF
Sara Murray, MD, MAS, associate professor, Division of Hospital Medicine at UCSF Health; associate chief medical information officer, Inpatient Care and Data Science, UCSF Health.
Arizona Telemedicine Program Southwest Telehealth Resource Center Artificial Intelligences Virtual nursing assistants Population health management Automated health records Remote patient monitoring.
A new palm oil substitute called PALM-ALT has been developed by researchers at Queen Margaret University in Scotland. The plant-based ingredient is shown to be healthier, as well as 70% better for the environment than conventional palm oil and is described as “the holy grail to replace it.”
Food experts at Queen Margaret University (QMU) in Edinburgh have developed a new ingredient which has the potential to replace palm oil in bakery products. The new substitute is both healthier and more environmentally friendly than palm oil, which is currently used in a vast amount of baked goods. This could be a game-changing solution for the food industry, allowing manufacturers to satisfy increasing demand for tasty, lower fat, healthier products, whilst also reducing deforestation of the world’s rainforests.
Global cancer cases in those under 50 surged by 79% over the past 30 years, with breast, windpipe, and prostate cancers leading the rise. The findings call for a global strategy emphasizing prevention, early detection, and tailored treatments for younger patients.
There’s been a striking 79% increase in new cases of cancer among the under 50s around the world over the past three decades (1990−2019), finds research published in the open-access journal BMJ Oncology.
Breast cancer accounted for the highest number of ‘early onset’ cases in this age group in 2019. But cancers of the windpipe (nasopharynx) and prostate have risen the fastest since 1990, the analysis reveals. Cancers exacting the heaviest death toll and compromising health the most among younger adults in 2019 were those of the breast, windpipe, lung, bowel, and stomach.
A collaboration between researchers at the University of Illinois Urbana-Champaign and Duke University has developed a robotic eye examination system, and the National Institutes of Health has awarded the researchers $1.2 million to expand and refine the system.
The researchers have developed a robotic system that automatically positions examination sensors to scan human eyes. It currently uses an optical scan technique which can operate from a reasonably safe distance from the eye, and now the researchers are working to add more features that will help it perform most steps of a standard eye exam. These features will require the system to operate in closer proximity to the eye.
“Instead of having to spend time in a doctor’s office going through the manual steps of routine examinations, a robotic system can do this automatically,” said Kris Hauser, a U. of I. computer science professor and the study’s principal investigator. “This would mean faster and more widespread screening leading to better health outcomes for more people. But to achieve this, we need to develop safer and more reliable controls, and this award allows us to do just that.”
Generative artificial intelligence – the kind of AI behind the hugely popular ChatGPT application – already is disrupting the healthcare industry. C-suite executives and other health IT leaders at provider organizations need to know much to keep up and what to be wary of.
Venky Anant is a partner at research and consulting firm McKinsey Digital. He is our guest on this week’s podcast. He has vast expertise in AI and knows well its disruptive potential.
Leveraging Technology For Innovative, Patient-Centered Clinical Care — Dr. Peter Fleischut, MD — Group Senior Vice President And Chief Information & Transformation Officer, NewYork-Presbyterian Hospital
Dr. Peter M. Fleischut, M.D., is Group Senior Vice President and Chief Information and Transformation Officer at NewYork-Presbyterian (https://www.nyp.org/)where he oversees the strategic vision and management of enterprise information technology, lab operations, pharmacy operations, innovation, data and analytics, artificial intelligence, telemedicine, and cybersecurity.
Dr. Fleischut has led the development of the Hospital’s award-winning digital health services and the implementation of clinical operations at NewYork-Presbyterian David H. Koch Center, a world-class ambulatory care center. In his previous role as Senior Vice President and Chief Transformation Officer, he focused on creating a single electronic medical record across NewYork-Presbyterian and its affiliated medical schools, Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons.
